Association of the insulin gene polymorphism and colorectal cancer

AuthorMaral Arkanien
AuthorAkram Safaeien
AuthorKhatoon Karimien
AuthorElham Arbabien
AuthorFatemeh Rostamien
AuthorMitra Imanen
AuthorParvane Mohammadien
AuthorElham Hamzeieen
AuthorMohsen Vahedien
AuthorReza Mohebien
AuthorMohamad Vafaeien
AuthorReza Fatemien
Issued Date2012-03-31en
Abstract  Introduction: Some studies have determined that polymorphism in insulin gene are associated with increased insulin level and resistant to insulin and also cause to increase risk of colorectal cancer (CRC). The goal of this study was to evaluate incidence of the insulin gene polymorphism (rs689) in an Iranian population and to investigate the role of this polymorphism in increased risk of CRC.   Materials and Methods: Genotyping of the insulin gene were determined in a series of 110 colorectal cancer patients and 110 controls by using polymerase chain reaction and restriction fragment length polymorphism genotyping assays (PCR-RFLP).   Results: P value for genotype AT compared with AA, was 0.052 (OR=1.88, CI=0.99-3.5) and TT versus AA was 0.57 (OR=1.33 CI=0.48- 3.6). The results showed that the insulin gene polymorphism (rs689) is not a predisposing factor to increased risk to CRC (P=0.14). Incidence of mutant allele between patients and controls had no significant differences (OR=1.53 95% CI=0.98- 2.39, Pe=0.057).   Conclusion: These findings suggest that the insulin gene polymorphism (rs689) is not associated with increased risk of CRC.en
DOIhttps://doi.org/en
KeywordPolymorphism, Colorectal neoplasms, Insulin resistance, rs 689en
Keywordچند شکلی در ژنتیک، نورویش‌های کولون و راست روده، مقاومت به انسولین، 689 rsen
PublisherBrieflandsen
TitleAssociation of the insulin gene polymorphism and colorectal canceren
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
article-1-1155-fa.pdf.pdf
Size:
156.02 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF

Collections